Response to Comments: MolDx: MGMT Promoter Methylation Analysis DL36113

This document (A54607) is a response-to-comments record for MolDx DL36113 concerning MGMT promoter methylation analysis and does not itself specify coverage criteria, indications, or limits. For actionable coverage rules, clinical criteria, and documentation requirements, refer to the primary policy DL36113 and any final MolDx coverage determination; this extraction could not find explicit coverage criteria in the provided text.